Institutional investors purchased a net $9.4 million shares of PLX during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 10.45% of shares outstanding that institutional investors hold is actually below the Services to the Health Industry industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
OPALEYE MANAGEMENT, INC. Bought 1.9 Million shares of Protalix Biotherapeutics ...
RENAISSANCE TECHNOLOGIES LLC Bought 1.4 Million shares of Protalix Biotherapeutics ...